4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-26-079376
Chief Scientific Officer sold 16,105 shares at $20.01 ($322,261)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Reich Kristian Chief Scientific Officer | 2026-07-15 | Sale 10b5-1 | −16,105 | $20.01 | $322,261 | 2,808,446 | I |
| Open-market sales · 16,105 sh · avg $20.01 · $322,261 | |||||||
Loading xslF345X06/ownership.xml…